 |
|
| CLINICAL TRIALS IN HEART DISEASE
| |
| | |
|
|
A Companion to Braunwald's Heart Disease
To order this title, and for more information, click here
Second Edition
By
JoAnn Manson, MD, DrPH, Professor of Medicine, Harvard Medical School; Chief, Division of Preventive Medicine, Brigham and Women's Hospital, Boston, MA
Julie Buring, ScD, Professor of Ambulatory Care and Prevention, Harvard Medical School; Deputy Director, Division of Preventive Medicine, Brigham and Women's Hospital, Boston, MA
Paul Ridker, MD, MPH, Associate Professor of Medicine, Harvard Medical School Director of the Center for Cardiovascular Disease Prevention, Director
of Cardiovascular Disease Research, Co-Director of Blood Studies, Division of Preventive Medicine, Brigham and Women's Hospital, Harvard
School of Medicine, Brigham and Women's Hospital, Boston, MA
J. Michael Gaziano, MD, MPH, Associate Professor of Medicine, Harvard Medical School, Co-Director of Cardiovascular Disease Research and Co-Director of Blood
Studies, Division of Preventive Medicine, Brigham and Women's Hospital, Preventive Medicine Division, Boston, MA
Description
This new edition covers important new trials in cardiology therapies and prevention of cardiovascular problems. The world authorities
on pharmacologic clinical trials write about the trials, the outcomes and importance for clinical practice.
This book gives the general
cardiologist insight into the development of new therapies in cardiology as well as the process of how trials were used for those therapies.
In addition to providing a manual for how to establish trials, trials for treatment and prevention are covered.
Audience
General cardiologists, Cardiology Fellows in training, Cardiovascular Epidemiologists
Contents
Section I. METHODOLOGY
Chapter 1: Contributions of Basic Research, Observational Studies, and Randomized Trials
Chapter
2: Methodology of Randomized Trials
Chapter 3: Comparative Features of Primordial, Primary and Secondary Prevention Trials
Chapter
4: Principles of Data and Safety Monitoring Boards in Randomized Trials
Section II. TREATMENT TRIALS
A.
Treatment of Acute Coronary Ischemia
Chapter 5: Aspirin and Thienopyridines
Chapter 6: Heparin and Low Molecular Weight Heparin
in Acute Coronary Ischemia
Chapter 7: Clinical Trials in Thrombolytic Therapy
Chapter 8: Clinical Trials of Direct Thrombin Inhibitors
Chapter
9: Glycoprotein IIb/IIIa Receptor Inhibitors
Chapter 10: Adjunctive Medical Therapy for Acute Myocardial Infarction
Chapter 11:
Primary, Rescue and Adjunctive Mechanical Intervention in the Setting of Acute Myocardial Infarction
Chapter 12: Coronary Artery Bypass
Surgery in Acute Coronary Syndromes
B. Treatment of Arrhythmias
Chapter 13: Drug Therapy for Ventricular Tachycardia
and Ventricular Fibrillation
Chapter 14: Antiarrhythmic Drug Therapy in Supraventricular Tachycardia
Chapter 15: Anticoagulant
and Antiplatelet Drug Therapy for Atrial Fibrillation
Chapter 16: Clinical Trials in Arrhythmia Ablation
Chapter 17: Clinical Trials
of Implantable Cardioverter-Defibrillators (ICDs) and Cardiac Resynchronization Therapy/Defibrillation
Chapter 18: Clinical Trials
in Pacing
C. Treatment of Congestive Heart Failure
Chapter 19: Drugs Blocking the Renin-Angiotensin-Aldosterone System
(RAAS)
Chapter 20: Beta-blocker Treatment of Heart Failure
Chapter 21: Clinical Trials in Heart Transplantation and Mechanical
Cardiac Support for End-Stage Heart Failure
Section III. PRIMARY AND SECONDARY PREVENTION TRIALS
Chapter
22: Cholesterol Reduction
Chapter 23: Blood Pressure Reduction Treatment Trials
Chapter 24: Prevention Trials of Smoking Cessation
Chapter
25: Physical Activity and Weight Loss
Chapter 26: Aspirin, Other Antiplatelet Agents, and Anticoagulant Agents in the Secondary and
Primary Prevention of Cardiovascular Disease
Chapter 27: Postmenopausal Hormone Replacement Therapy
Chapter 28: Antioxidant Vitamins
Chapter
29: Dietary Factors
Chapter 30: Cardiac Psychology/Behavioral Cardiology
Chapter 31: Multiple Risk Factor Intervention Trials
Chapter
32: Prevention Strategies: From the Office to the Community and Beyond
| Bibliographic details |
Hardbound, 448 pages, publication date: JUN-2004
ISBN-13: 978-0-7216-0408-4
ISBN-10: 0-7216-0408-0
Imprint: SAUNDERS
|
042/423
Last update: 3 Oct 2009
|
|
| |
| | |
|
|
| |
Home | Elsevier Sites | Privacy Policy | Terms and Conditions | Feedback | Site Map | A Reed Elsevier Company